ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 2 3 , 20 2 3 Cambridge, MA (U.S.) and Lyon (France), May 24 , 202 3 – ERYTECH Pharma ( Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by
PRESS RELEASE ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes Lyon (France), May 23, 2023 - ERYTECH Pharma ( Nasdaq & Euronext : ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating
Monthly information related to total number of voting rights and shares composing the share capital _ May 15, 202 3 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN
Monthly information related to total number of voting rights and shares composing the share capital _ April 3 0 , 202 3 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
ERYTECH Provides Business and Financial Update for the First Quarter of 2023 Combination with Pherecydes , i ntending to c reate a g lobal l eader in e xtended p hage t herapies to t arget antimicrobial resistant p athogenic b acteria to be submitted to shareholders' vote in June 2023 Cash
ERYTECH Announces Approval to Transfer its Listing to the N asdaq Capital Market Cambridge, MA (U.S.) and Lyon (France), April 1 7 , 20 2 3 – ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances
Monthly information related to total number of voting rights and shares composing the share capital _ March 31 , 202 3 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 20 2 2 Combination with Pherecydes a nnounced , i ntending to c reate a g lobal l eader in e xtended p hage t herapies t argeting antimicrobial resistant p athogenic b acteria Deep restructuring
Monthly information related to total number of voting rights and shares composing the share capital _ January 3 1 , 202 3 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
Monthly information related to total number of voting rights and shares composing the share capital _ December 3 1 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
